Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12

By Bernstein D.I.   Smith V.E.   Sherwood J.R.   Schiff G.M.   Sander D.S.   DeFeudis D.   Spriggs D.R.   Ward R.L.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 381-387

Elsevier

Access to resources Recommend Favorite

Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system

By Fries L.F.   Tartaglia J.   Taylor J.   Kauffman E.K.   Meignier B.   Paoletti E.   Plotkin S.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 428-434

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants

By Clements-Mann M.L.   Dudas R.   Hoshino Y.   Nehring P.   Sperber E.   Wagner M.   Stephens I.   Karron R.   Deforest A.   Kapikian A.Z.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4676-4684

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates

By Baqar S.   Bourgeois A.L.   Schultheiss P.J.   Walker R.I.   Rollins D.M.   Haberberger R.L.   Pavlovskis O.R.  

Vaccine, Vol. 13, Iss. 1, 1995-01 ,pp. : 22-28

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vaccine in human volunteers

By von Specht B.-U.   Lucking H.C.   Blum B.   Schmitt A.   Hungerer K.D.   Domdey H.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1111-1117

Elsevier

Access to resources Recommend Favorite